Embase Content Update: Journals Previously Indexed via Medline

When is this happening?

Rollout began July 2026 and will be phased across the affected journals rather than a single cutover date. The transition will finish in September.

Why do some journals no longer appear as 'Medline unique' in Embase?

Embase has expanded its direct publisher relationships to cover a large number of journals that were previously sourced exclusively via Medline/PubMed. These titles are now ingested directly from publishers into the Embase collection. As a result, they are no longer classified as 'Medline unique' — they are fully part of the Embase collection in their own right. There is no change to journal coverage; these titles remain available in Embase.

Does this affect what content I can find in Embase?

No journals have been removed. All titles affected by this change continue to be indexed in Embase. The total scope of Embase coverage is maintained; what changes is the source and processing pathway for these journals.

Why is Embase making this change?

This change is part of Embase's strategy to build direct content relationships with publishers. Direct ingestion means these journals become available in Embase faster, benefit from richer Embase-specific indexing (including Emtree, drug and disease terms), and gain more stable long-term coverage than a third-party pipeline can provide.

Will this affect API or dataset access?

No. This change affects how content is indexed and classified within Embase; it does not change the structure or volume of the content.

Will the indexing quality change for these journals?

Yes — and in most respects for the better. New records from these journals will receive automatic indexing of title, abstract and keywords, including Emtree subject headings, drug and disease indexing, and other Embase-specific enrichment. Previously, these records carried PubMed/MeSH-based indexing. This means searches using Emtree terms will now return more complete results for these journals.

Will these journals be indexed the same way as all other Embase journals?

Not exactly — and it is important to understand the difference. Most journals in Embase go through two indexing stages: automatic indexing of title, abstract and keywords, followed by manual full-text indexing by specialist indexers. Journals in this transition group will receive automatic indexing of title, abstract and keywords only — the same as the first stage for regular Embase journals, but without the additional manual full-text indexing layer. This means their indexing depth will be richer than what was previously provided via Medline/MeSH, but it will not be equivalent to a fully manually indexed Embase journal. Users who rely on deep manual indexing for comprehensive systematic reviews should be aware of this distinction.

Will my existing search strategies be affected?

This is a forward-looking change — it does not alter results for past date ranges. From the transition date, new records from the affected journals will no longer be classified as 'Medline unique' as they're added to Embase. So a search or alert covering new content will return fewer 'Medline unique' results for these journals — not because content has been removed, but because new records are tagged differently. If you re-run a saved search restricted to a date range before the transition, results are unchanged, since those journals were still classified as Medline-unique for that period. This matters most for systematic reviewers who use the Medline-unique filter as a deduplication proxy when combining PubMed and Embase searches: the filter will stop catching these journals only for records added after the transition. We recommend reviewing any saved searches or alerts that use this filter so you know what to expect.

Does this affect how I should deduplicate results between PubMed and Embase?

No — deduplication should not be affected. Embase records have the same structure regardless of source — whether a record is sourced via Medline/PubMed or ingested directly from the publisher does not change how the record is built. Deduplication tools typically match on DOI or PMID rather than on record structure, and Embase will continue to extract and display the PMID for records from these journals. This means PMID-based deduplication workflows should continue to work as before. We recommend testing your deduplication workflow on a sample set.

Will historical records for these journals be updated?

No. Records indexed before the migration retain their original Medline-sourced indexing and remain available in Embase as before. Only records received after the transition date will carry automatic indexing of title, abstract and keywords. If you need to identify the transition point for a specific journal, please contact Embase Support.

Will I notice any change in how quickly new records appear?

Records from these journals may appear in Embase faster than before, since content is now received directly from publishers rather than via the Medline processing pipeline.